Your Partner. For science. For life.

Battling chronic ailments. Evolving science. Improving quality of life. Even helping people get a better night’s sleep. Our portfolio companies are positively impacting the world every day with their visionary people and life-changing products.

What they do.

Xalud is developing gene therapy and small molecule programs that resolve the root cause issues relating to pain and inflammatory conditions without utilizing opioids. The company is planning to seek indications for the three leading programs for neuropathic pain, osteoarthritis and acute, modest-to-severe pain.


PBM partnered with an accomplished group of physicians and scientists with decades of experience in the areas of pain and inflammation. PBM is providing capital and operational assistance to advance the Xalud platform. Xalud is targeting to be in multiple clinical trials in 2017.

Achievement of note:

Xalud has conducted several dog studies where dogs that were going to be euthanized due to pain and immobility dramatically improved their health. They were able to walk, jump, play and climb stairs again. Xalud is exploring advancing these key compounds for both human and veterinary applications.

How they’re improving the quality of people’s lives:

Xalud is developing non-opioid drugs that could help over 30 million people in the United States suffering from pain. Hopefully, with Xalud’s products, these patients would be able to experience life without daily pain. They would have more mobility and happiness —all without the terrible side effects and potentially addictive attributes from opioids. Development of a reliable, non-opioid pain treatment also has the potential to alleviate the existing opioid crisis in the United States.